Join to View Full Profile
5 west sample RdDeerfield Beach, FL 33064
Phone+1 954-782-1700
Fax+1 954-782-7490
Dr. Danzig is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- SUNY Downstate Health Sciences UniversityResidency, Ophthalmology, 2007 - 2009
- Crozer-Chester Medical CenterInternship, Transitional Year, 2004 - 2005
- Lewis Katz School of Medicine at Temple UniversityClass of 2004
Certifications & Licensure
- FL State Medical License 2011 - 2027
- CA State Medical License 2006 - 2025
- TX State Medical License 2009 - 2025
- PA State Medical License 2004 - 2005
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Compulink Advantage EHR, Compulink, 2012-2014
Publications & Presentations
PubMed
- Faricimab Treat-and-Extend Dosing for Macular Edema due to Retinal Vein Occlusion: 72-Week Results From the BALATON and COMINO Trials.Carl J Danzig, Christiana Dinah, Faruque Ghanchi, Lars-Olof Hattenbach, Arshad M Khanani
Ophthalmology. Retina. 2025-03-17 - Patient Preferences with Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Multinational...Alfredo García-Layana, Gloria C Chi, Laurent Kodjikian, Mariacristina Parravano, David Chow
Ophthalmic Research. 2025-01-01 - 3 citationsVision Loss Reduction with Avacincaptad Pegol for Geographic Atrophy: A 12-Month Post Hoc Analysis of the GATHER1 and GATHER2 Trials.Carl J Danzig, Arshad M Khanani, Peter K Kaiser, Margaret A Chang, Jaclyn L Kovach
Ophthalmology. Retina. 2024-11-01
Authored Content
- Faricimab Appears Comparable to Ranibizumab Through 52 WeeksOctober 2020
- Risk Factors for Poor Outcomes After Vitrectomy for Macular HoleDecember 2018
- Risk Factors for Poor Outcomes After Vitrectomy for Macular HoleDecember 2018
- Does ILM Peeling Improve Outcomes in Epiretinal Membrane Surgery?June 2018
- Join now to see all
Press Mentions
- Oculis Accelerates Enrollment for Phase 3 DIAMOND Trials of OCS-01 Eye Drops in DMEOctober 21st, 2024
- Results from the Phase 3 BALATON and COMINO Studies at 72 WeeksJuly 18th, 2024
- Medical Spa Marianna, FlJanuary 14th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
